Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc > Data

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Feb 22, 2024 12:47pm

89 Views

Post# 35893609

RE:RE:Data

As per pg 14 and 18 of the Anual Meeting Presentation:

"At 90 patients Baxter will have access to raw data (no statistical analysis)… potential opportunity to release crude data to broader audience"

"Spectral Catalysts

• Tigris interim patient enrollment - 90 patients / Baxter milestone payment #2

• Release of crude mortality data at 90 patients"

https://spectraldx.com/wp-content/uploads/2023/06/Spectral-agm-2023-presentation.pdf

<< Previous

Bullboard Posts

Next >>

Rock Tech notches official permit for German lithium refinery